This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,290.59 firm-fixed price delivery order contract is for the supply of febuxostat 40 mg tablets. The contract has an ultimate completion date of November 7, 2024.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that larger IDC.
The contract award did not include any set-aside designations, indicating open competition. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) through June 2025. The company has established itself as a key vendor for federal healthcare programs, with a significant focus on supporting the DLA and other Department of Defense medical requirements.
Generated 2/5/25, 9:12 AM